Replay available

Item 9 Labs Corp (INLB) Q2 2022 Earnings Call

Item 9 Labs Corp (OTC: INLB) Q2 2022 earnings conference call, held 2022-05-16. Replay captured from the company's public earnings webcast.

Mon, May 16, 2022 at 4:30 PMendedReplay
Item 9 Labs Corp (INLB) Q2 2022 Earnings Call

Hosted by

Featured presenters

Jason Assad

Investor Relations

Andrew Bowden

Chief Executive Officer

Bobby Michelson

Chief Financial Officer

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Item 9 Labs Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:03.651 Hello, this is Jason Assad, Investor Relations with Item 9 Labs. 00:00:03.651 -- 00:00:07.431 Good afternoon and welcome to Item 9 Labs Fiscal 00:00:07.872 -- 00:00:13.135 Q2 2022 Results Conference Call for the three months ended March 31st, 2022. 00:00:13.135 -- 00:00:17.376 Joining me on today's call is our Chief Executive Officer, Andrew Bowden, and our Chief 00:00:17.376 -- 00:00:22.259 Financial Officer, Bobby Michelson. Shortly before this call, we filed our Form 10-Q, 00:00:22.259 -- 00:00:27.220 a copy of which is available on the company's website at item9labscorp.com. 00:00:28.154 -- 00:00:32.337 That's item the number nine labs or dot com. 00:00:32.337 -- 00:00:35.139 I'll start our call today by reading the safe harbor statement. 00:00:35.139 -- 00:00:39.482 The statement is made pursuant to the safe harbor for forward looking statements described 00:00:39.482 -- 00:00:43.934 in the Private Securities Litigation Reform Act of 1995. 00:00:44.066 -- 00:00:48.409 All statements made in this call, with the exception of historic facts, may be considered 00:00:48.409 -- 00:00:51.121 forward looking statements within the meaning of Section 27 A of the Securities Act of 00:00:51.121 -- 00:00:54.682 1933 and Section 21 E of the Securities Act of 1934. 00:00:58.072 -- 00:01:02.455 Although we believe expectations and assumptions reflected in these forward-looking statements 00:01:02.455 -- 00:01:07.017 are reasonable, we can make no assurance that such expectations will prove to be correct. 00:01:07.017 -- 00:01:11.240 Actual results may differ materially from those expressed or implied in forward-looking 00:01:11.240 -- 00:01:13.741 statements due to various risks and uncertainties. 00:01:13.741 -- 00:01:18.284 For discussion o...